This is a preview of subscription content, log in via an institution to check access.
Notes
Pharmacoeconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from more than 1600 journals. The use of tradenames, identified by [‘~’] or the use of a registered (®) or trademark (™) symbol, is for product identification purposes only and does not imply endorsement.
Ipratropium bromide, tiotropium bromide, or salbutamol [albuterol]/ipratropium bromide.
Costs included those relating to initial hospitalization, readmission, staffing, support services, building overheads, and community services.
Consisting of a multidisciplinary team that includes geriatric nurses, a pharmacist, and a social worker.
Costs included direct medical care costs related to hospitalization, including physician services, services of other healthcare professionals, medications, diagnostic and therapeutic procedures, laboratory tests, and per-diem costs.
Administered ≥4 doses of DTaP vaccine; ≥3 doses of poliovirus vaccine; ≥1 dose of measles, mumps, and rubella virus vaccine; ≥3 doses of Hib vaccine; and ≥3 doses of hepatitis B vaccine.
The patients (n = 396) were aged ≥21 years, with asthma.
Costs were total medical costs adjusted to 2002 values and discounted at 3% per annum.
Enalapril, captopril, ramipril, lisinopril, and quinapril.
Carvedilol, atenolol, metoprolol tartrate, and metoprolol succinate.
References
Mitka M. Less may be more when managing patients with severe chronic illness. JAMA 2006 Jul 12; 296(2): 159–60
References
Van der Borght S, Rinke de Wit TF, Janssens V, et al. HAART for the HIV-infected employees of large companies in Africa. Lancet 2006 Aug 5; 368(9534): 547–50
References
Spence MM, Hui R, Chan J. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit. J Manag Care Pharm 2006 Jun; 12(5): 377–82
References
O’Reilly J, Lowson K, Young J, et al. A cost effectiveness analysis within a randomised controlled trial of post-acute care of older people in a community hospital. BMJ 2006 Jul 29; 333(7561): 228–31
References
Weidle PJ, Wamai N, Solberg P, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. Epub 2006 Aug 4
Gill CJ. Antiretroviral programme in rural Uganda. Lancet. Epub 2006 Aug 4
References
Jayadevappa R, Chhatre S, Weiner M, et al. Health resource utilization and medical care cost of acute care elderly unit patients. Value Health 2006 May–Jun; 9(3): 186–92
References
Smith PJ, Stevenson J, Chu SY. Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coverage. Pediatrics 2006 Jun; 117(6): 1972–8
References
Wyrwich KW, Metz SM, Kroenke K, et al. Interpreting quality-of-life data: methods for community consensus in asthma. Ann Allergy Asthma Immunol 2006 Jun; 96(6): 826–33
References
Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960–2000. N Engl J Med 2006 Aug 31; 355(9): 920–7
References
UK National Institute for Clinical Excellence. NICE welcomes new initiative to help NHS reduce spending on treatments that do not improve patient care. Media release 2006 Sep 5 [online]. Available from URL: http://www.nice.org.uk/download.aspx?o=360944 [Accessed 2006 Oct 16]
References
Cole JA, Norman H, Weatherby LB, et al. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy 2006 Aug; 26(8): 1157–64
Rights and permissions
About this article
Cite this article
Disease Management Update. Dis-Manage-Health-Outcomes 14, 321–325 (2006). https://doi.org/10.2165/00115677-200614050-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-200614050-00006